LDOS

Business profile & competitive position

Leidos Holdings, Inc. is classified in the Technology sector under Information Technology Services. That label places it among companies that design, integrate, and operate technology systems and services rather than hardware or software products. The business model typically relies on long-term client relationships, contract renewals, and the ability to bid on large, multi-year programs. Using the numbers we have as a lens, the company’s 7.9% net margin is not the sky-high margin associated with software royalties or platform businesses, but it is respectable for a services-heavy model where labor and program costs eat up a large portion of revenue. More striking is the 27.6% return on equity (ROE), which is high relative to the net margin. In a services firm, an ROE that far above the margin usually points to efficient capital use, active capital return programs, or a relatively low equity base. What it suggests to a researcher is that management has been effective at generating profit from the capital invested, even without charging monopoly-like prices. The economic moat therefore likely rests on contract stickiness, specialized technical expertise, scale in bidding, and compliance barriers that make it harder for smaller competitors to displace an incumbent. Those are qualitative conclusions supported by the quantitative signature—high capital efficiency on moderate margins—not by brand narrative alone.

Financial posture

Leidos currently carries a market capitalization of $17.3 billion and trades at a price-to-earnings ratio of 12.7. That multiple sits well below the premium valuations typical of high-growth Technology names, which tells us the market is treating LDOS more like a mature, cash-generative contractor than a disruptive tech story. The 7.9% net margin confirms a steady, profitable operation, while the 27.6% ROE shows the company is among the more efficient capital allocators in its peer set. The 0.55 beta is perhaps the most telling figure: the stock has historically moved roughly half as much as the overall market. Low-beta profiles are common in businesses backed by stable, recurring revenue streams, such as government or regulated-health IT spending. Taken together, the valuation and risk metrics describe a company priced for reliability rather than explosive expansion. There is no explicit debt figure in the provided data, so we cannot comment on leverage, but the combination of a sub-13x P/E, a near-8% margin, and a mid-20s ROE gives the equity a value-and-quality appearance on paper. Investors should note, however, that low multiples can also signal doubt about future growth acceleration or concerns about segment mix.

Macro & geopolitical exposure

Because Leidos sits in Information Technology Services and recent discussions center on “defense growth amid health reset,” the relevant macro exposures are mostly policy- and budget-driven. Service providers that serve public-sector clients are tied to federal budget appropriations, defense and intelligence spending authorizations, and healthcare program funding. Shifts in any of those areas—whether through continuing resolutions, debt-ceiling debates, or program cancellations—can alter contract flow and backlog visibility. The industry is also exposed to regulatory compliance: contractors must meet evolving cybersecurity, data-privacy, labor, and procurement standards before they can even bid on certain work, which raises barriers to entry but also raises compliance costs. Geopolitical tensions can increase demand for defense and intelligence technology, while health-policy changes can shift priorities in the civilian agency book. Currency and commodity cycles matter less here than they do for manufacturers or exporters, because the service revenue is largely domestic and labor-based. Interest rates still play a role, since they affect the cost of financing large IT infrastructure rollouts and can pressure valuation multiples for capital-intensive or long-duration cash-flow businesses.

Recent developments

The most recent news cluster follows the Q2 2026 earnings release on August 4, 2026. The August 4 Seeking Alpha transcript gives the full management commentary, while Zacks and MarketBeat recaps published on August 5 framed the quarter’s narrative. A Zacks headline on August 5 read “LDOS Q2 Earnings Call Highlights Defense Growth Amid Health Reset,” suggesting the investment discussion is centered on strength in defense-oriented work offsetting repositioning in the health segment. A separate Zacks article on August 6 titled “Here’s Why Leidos (LDOS) is a Strong Growth Stock” pushed the growth-stock angle in the days after the print. MarketBeat also published “Leidos Q2 Earnings Call Highlights” on August 5. These headlines collectively indicate that post-earnings attention has focused on segment mix, defense momentum, and how the company is resetting its health business—not just the headline EPS number.

Earnings behavior & post-earnings drift

Leidos has a perfect earnings record over the last eight reported quarters, with a beat rate of 8/8 (100%) and an average earnings surprise of 16%. On the surface, that is an exceptional track record. Yet the post-earnings price behavior tells a more nuanced story. The average 5-day price move after earnings across those eight quarters is only 0.25%, classified as “flat.” The most recent prints illustrate why. On August 4, 2026, the company reported EPS of $3.26 versus an estimate of $2.91, a 12% surprise, but the stock fell 2.87% the next day and was essentially unchanged (0%) over the following five sessions. The prior quarter, May 5, 2026, delivered EPS of $3.13 vs. $2.90, a 7.9% beat, but the stock dropped 1.67% the next day and 6.41% over the next five days. Not every beat was sold: the February 17, 2026 report showed EPS of $2.76 vs. $2.61 (5.7% surprise) and produced a 6.19% next-day gain and a 7.8% five-day gain. And the November 4, 2025 quarter delivered EPS of $3.05 vs. $2.71 (12.5% surprise), but the stock fell 2.25% the next day and 0.65% over five days. The takeaway is that simply beating earnings has not been enough to drive sustained upside; the market’s reaction appears to depend on guidance, segment commentary, and how much of the beat was already priced in. With the next report scheduled for November 3, 2026 before the open and a consensus EPS estimate of $3.14, the setup is less about whether Leidos can beat than about what the market has already assumed and what management says about defense and health momentum.

For a deeper look at how sell-side and institutional models are currently positioned ahead of the November 3 report, review the full institutional verdict and consensus breakdown on the platform.